Peptide set test: a peptide-centric strategy to infer differentially expressed proteins

Area of Science:

• Proteomics
• Biostatistics
• Cancer Research

Background:

• Clinical proteomics translation is hindered by technical variability and patient heterogeneity.
• Bottom-up proteomics indirectly measures proteins via peptides, posing challenges for differential expression analysis.

Purpose of the Study:

• To develop a peptide-centric method for improved differential protein expression analysis in proteomics.
• To address the limitations of indirect peptide measurements in distinguishing protein-level changes.

Main Methods:

• Introduced the peptide set test (PepSetTest) to detect coordinated peptide expression changes from the same protein.
• Compared PepSetTest performance against aggregation-based approaches using spike-in experiments and simulations.

Main Results:

• PepSetTest demonstrated enhanced sensitivity and precision compared to traditional aggregation methods.
• Analysis of breast cancer patient data revealed significant alterations in collagen XII peptide levels in tamoxifen-resistant tumors.
• Identified a potential association between collagen XII-mediated matrix reassembly and tamoxifen resistance.

Conclusions:

• The peptide set test is a powerful peptide-centric strategy for inferring differential protein expression.
• This method offers improved statistical power for clinical proteomics applications.
• PepSetTest provides novel insights into molecular mechanisms, such as tamoxifen resistance in breast cancer.